The differential gene expression of Notch receptors in primary and metastatic epithelial ovarian cancer sites

Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1

Abstract

Purpose of Investigation: Notch signaling belongs among the candidate pathways for targeted therapies in ovarian cancer. While Notch 3 and Notch 1 overexpression has already been confirmed in ovarian carcinomas compared to their benign counterparts, the expression in metastatic sites is still not well known. The aim of the current study was to compare the relative expression of the four Notch gene receptors between primary and metastatic sites of ovarian carcinomas. Materials and Methods: Seventeen paired couples of tissues, from primary and metastatic sites of epithelial ovarian cancer, were collected during the cytoreductive surgery. For the study of the gene expression Real-Time Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) was used. The analysis of the results was performed with the Comparative C T Method (ΔΔCt Method). Results: Notch 3 and 2 were overexpressed compared to Notch 1 and 4 in both primary and metastatic sites. Notch 3 showed the highest differential expression, yet none of the four Notch genes reached statistical significance due to the differences between different samples. Conclusions: The lack of statistical difference in the expression of all four genes between primary and metastatic sites of epithelial ovarian cancer, potentially predicts same treatment response in all intrabdominal tumours and render Notch pathway a suitable and promising candidate for targeted therapies. The high heterogeneity in the expression between the samples, highlights even more the need of personalized therapies. Further studies should include more patients, examine the absolute expression, extend to all histological types, and focus on the Notch intracellular domain expression.

Authors and Affiliations

I. C. Kotsopoulos, A. Papanikolaou, K. T. Papazisis, P. Touplikioti, D. Tsolakidis, A. F. Lambropoulos, B. C. Tarlatzis

Keywords

Related Articles

The differential gene expression of Notch receptors in primary and metastatic epithelial ovarian cancer sites

Purpose of Investigation: Notch signaling belongs among the candidate pathways for targeted therapies in ovarian cancer. While Notch 3 and Notch 1 overexpression has already been confirmed in ovarian carcinomas compared...

Diffusion magnetic resonance in cervical carcinoma: the role of apparent diffusion coefficient in the evaluation of treatment response

Purpose: The aim of the study was to determinate the role of apparent diffusion coefficient (ADC) in order to find cut-off values in the evaluation of treatment response. Materials and Methods: A retrospective study was...

The association of microcystic, elongated, and fragmented (MELF) invasion pattern in endometrial carcinomas with prognostic factors

Purpose: One of the most important prognostic factors for endometrial carcinoma (EC) is myometrial invasion. Microcystic, elongated, and fragmented (MELF) myometrial invasion (MI) pattern is also important in terms of di...

Expression of FOXA1 in breast cancer and the significance

Objective: The aim of this study to examine the expression of FOXA1, ER, and PR in breast cancer and investigate the association between FOXA1 expression and clinical parameters. Materials and Methods: One hundred one ca...

Resource utilisation and cost of cervical cancer and dysplasia in Croatia

Purpose of investigation: To analyse resource utilisation and costs due to cervical cancer and dysplasia in Croatia. Materials and Methods: Patients diagnosed with cervical cancer were identified from the Croatian Nation...

Download PDF file
  • EP ID EP663035
  • DOI 10.12892/ejgo4354.2019
  • Views 80
  • Downloads 0

How To Cite

I. C. Kotsopoulos, A. Papanikolaou, K. T. Papazisis, P. Touplikioti, D. Tsolakidis, A. F. Lambropoulos, B. C. Tarlatzis (2019). The differential gene expression of Notch receptors in primary and metastatic epithelial ovarian cancer sites. European Journal of Gynaecological Oncology, 40(1), 84-90. https://europub.co.uk/articles/-A-663035